Back to Index
Paulette Y. Mhawech-Fauceglia, MD
Professor of Clinical Pathology
CT 1200 North State Street Off Campus Los Angeles
+1 323 409 1313


After finishing her training in the United States and obtaining the American Board of clinical and anatomical Pathology, Dr. Fauceglia went back to Europe where she practiced Surgical Pathology in Geneva University Hospital an academic teaching institute for 4 years, concentrating on Uropathology and Gynecologic pathology. During her stay,she developed a special interest in urothelial bladder cancer and endometrial cancer.She was also involved in setting the research laboratory where she implemented and set up the tissue microarray technology (TMA).

Upon her return to the US, Dr. Fauceglia took a position at Roswell Park Cancer Institute (RPCI) where she concentrated mostly on gynecologic pathology. She has since helped the gynecologic-oncology service to become the best patient care service and was a referral pathologist to most of the Gynecologic cases for the community. During her work at RPCI, Dr. Fauceglia has succeeded in publishing numerous manuscripts, most of which are in translational research. She also heavily supports the gynecology-oncology research program and the vaccine trial program headed by Dr. Kunle Odunsi at RPCI.

At the present time at USC, Dr. Fauceglia had numerous collaborative research projects with Dr. Simon Gaythner and his team in preventive medicine studying the gene profiling of ovarian cancer. As well as with the Gyn-Oncologic research team guided by Dr.yvonne Lin


Metastatic Acinic Cell Carcinoma to the Vagina: A First Reported Case. Appl Immunohistochem Mol Morphol. 2017 Aug 09. View in: PubMed

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma. J Surg Oncol. 2017 Aug 08. View in: PubMed

High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer. Gynecol Oncol. 2017 Jul; 146(1):153-160. View in: PubMed

Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response. Gynecol Oncol. 2016 Dec; 143(3):650-654. View in: PubMed

Targeting Src in endometriosis-associated ovarian cancer. Oncogenesis. 2016 Aug 15; 5(8):e251. View in: PubMed

Microfocus of Anaplastic Carcinoma Arising in Mural Nodule of Ovarian Mucinous Borderline Tumor With Very Rapid and Fatal Outcome. Int J Gynecol Pathol. 2016 Jul; 35(4):348-51. View in: PubMed

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma. Ann Oncol. 2016 Jul; 27(7):1257-66. View in: PubMed

Nestin: A biomarker of aggressive uterine cancers. Gynecol Oncol. 2016 Mar; 140(3):503-11. View in: PubMed

RUNX1 prevents oestrogen-mediated AXIN1 suppression and ß-catenin activation in ER-positive breast cancer. Nat Commun. 2016 Feb 26; 7:10751. View in: PubMed

Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol. 2015 Nov; 139(2):261-7. View in: PubMed

Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis. Int J Cancer. 2015 Oct 15; 137(8):1806-17. View in: PubMed

Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis. Oncogene. 2015 Oct; 34(43):5418-26. View in: PubMed

Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new. J Clin Pathol. 2015 Sep; 68(9):710-7. View in: PubMed

Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series. Gynecol Oncol Rep. 2015 Aug; 13:36-9. View in: PubMed

Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare, often unrecognized collision tumor. Gynecol Oncol Rep. 2015 Aug; 13:8-12. View in: PubMed

PAX8 expression in ovarian surface epithelial cells. Hum Pathol. 2015 Jul; 46(7):948-56. View in: PubMed

MOLECULAR FINGERPRINTS OF MIXED ENDOMETRIOID AND SEROUS ADENOCARCINOMA OF THE ENDOMETRIUM: IGCS-0044 Uterine Cancer, including Sarcoma. Int J Gynecol Cancer. 2015 May; 25 Suppl 1:68. View in: PubMed

Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer. Cancer Microenviron. 2015 Apr; 8(1):23-31. View in: PubMed

NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer. Int J Cancer. 2015 Mar 15; 136(6):1390-401. View in: PubMed

Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium. PLoS One. 2015; 10(7):e0130909. View in: PubMed

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Epigenetics. 2015; 10(8):736-48. View in: PubMed

Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy. Cancer Microenviron. 2014 Aug; 7(1-2):33-9. View in: PubMed

Expression of DNA repair proteins in endometrial cancer predicts disease outcome. Gynecol Oncol. 2014 Mar; 132(3):593-8. View in: PubMed

Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer. PLoS One. 2014; 9(8):e104099. View in: PubMed

Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS One. 2014; 9(1):e84941. View in: PubMed

Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer. Cancer Immunol Res. 2014 Jan; 2(1):37-49. View in: PubMed

Developmentally restricted differentiation antigens are targets for immunotherapy in epithelial ovarian carcinoma. Int J Gynecol Pathol. 2013 Nov; 32(6):536-40. View in: PubMed

AKT inhibition mitigates GRP78 (glucose-regulated protein) expression and contribution to chemoresistance in endometrial cancers. Int J Cancer. 2013 Jul; 133(1):21-30. View in: PubMed

Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma. Gynecol Oncol. 2013 Jul; 130(1):174-80. View in: PubMed

ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases. Histopathology. 2013 Jun; 62(7):976-85. View in: PubMed

A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest. 2013 May; 93(5):528-42. View in: PubMed

Lower extremity pain as initial presentation of cervical cancer. Gynecol Oncol Case Rep. 2013; 5:13-5. View in: PubMed

Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients. Cancer Immun. 2013; 13:1. View in: PubMed

Recurrent leiomyosarcoma presenting as malignant arterial tumor thrombus. Gynecol Oncol Case Rep. 2013; 4:32-4. View in: PubMed

Metastatic ovarian papillary serous carcinoma to the breast: Diagnosis and pitfalls. Gynecol Oncol Case Rep. 2013; 4:35-7. View in: PubMed

Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy. Transl Oncol. 2012 Dec; 5(6):469-74. View in: PubMed

Clinically aggressive primary solid pseudopapillary tumor of the ovary in a 45-year-old woman. Ann Diagn Pathol. 2012 Dec; 16(6):498-503. View in: PubMed

Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma. Gynecol Oncol. 2012 Oct; 127(1):198-201. View in: PubMed

Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer. Br J Cancer. 2012 Jul 10; 107(2):370-4. View in: PubMed

Pax-8 is a reliable marker in making the diagnosis in advanced stage epithelial ovarian carcinoma and primary peritoneal carcinoma for neoadjuvant chemotherapy on cell block and biopsy specimens. Histopathology. 2012 May; 60(6):1019-20. View in: PubMed

Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients. Proc Natl Acad Sci U S A. 2012 Apr 10; 109(15):5797-802. View in: PubMed

Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients. BMC Res Notes. 2012 Jan 24; 5:65. View in: PubMed

BRCAness profile of sporadic ovarian cancer predicts disease recurrence. PLoS One. 2012; 7(1):e30042. View in: PubMed

The role of hypoxic-inducible factor (HIF1a) and aldolaseC protein in endometrial carcinogenesis: a retrospective study of 279 patients. BMJ Open. 2012; 2(4). View in: PubMed

Synuclein-? (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma. Gynecol Oncol. 2012 Jan; 124(1):148-52. View in: PubMed

Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in Cisplatin cytotoxicity in vitro. PLoS One. 2012; 7(12):e51030. View in: PubMed

MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction. Patholog Res Int. 2012; 2012:960327. View in: PubMed

Aldolase mRNA expression in endometrial cancer and the role of clotrimazole in endometrial cancer cell viability and morphology. Histopathology. 2011 Nov; 59(5):1015-8. View in: PubMed

Malignant mixed müllerian tumor of primary peritoneal origin. Ann Diagn Pathol. 2011 Aug; 15(4):273-7. View in: PubMed

Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery. Int J Gynecol Pathol. 2011 May; 30(3):231-5. View in: PubMed

Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Clin Cancer Res. 2011 Apr 15; 17(8):2170-80. View in: PubMed

Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma. PLoS One. 2011 Mar 23; 6(3):e18066. View in: PubMed

Expression of poly (adenosine diphosphate-ribose) polymerase and p53 in epithelial ovarian cancer and their role in prognosis and disease outcome. Int J Gynecol Pathol. 2011 Mar; 30(2):139-44. View in: PubMed

Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium. Eur J Surg Oncol. 2010 Dec; 36(12):1195-201. View in: PubMed

Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma. PLoS One. 2010 Nov 08; 5(11):e15415. View in: PubMed

Pathogenesis of mediastinal paravertebral müllerian cysts of Hattori: developmental endosalpingiosis-müllerianosis. Int J Gynecol Pathol. 2010 Nov; 29(6):546-51. View in: PubMed

IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma. Am J Clin Pathol. 2010 Jun; 133(6):899-908. View in: PubMed

Ovarian yolk sac tumor associated with major fibrosarcoma component in a 13-year-old girl. Int J Gynecol Pathol. 2010 May; 29(3):252-5. View in: PubMed

Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci U S A. 2010 Apr 27; 107(17):7875-80. View in: PubMed

Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapy. Int J Gynecol Pathol. 2010 Mar; 29(2):193-6. View in: PubMed

Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes. Transl Oncol. 2009 Dec; 2(4):341-9. View in: PubMed

Submission of the entire lymph node dissection for histologic examination in gynecologic-oncologic specimens. Clinical and pathologic relevance. Gynecol Oncol. 2009 Dec; 115(3):354-6. View in: PubMed

Microsatellite instability in large cell neuroendocrine carcinoma of the female genital tract. Histopathology. 2009 Nov; 55(5):621-5. View in: PubMed

Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006. Gynecol Oncol. 2009 Nov; 115(2):249-56. View in: PubMed

Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer. Cancer Immun. 2009 Aug 26; 9:6. View in: PubMed

Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer. J Clin Pathol. 2009 Aug; 62(8):710-4. View in: PubMed

Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer Res. 2009 Jul 01; 69(13):5498-504. View in: PubMed

14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis. Eur J Surg Oncol. 2009 Jul; 35(7):763-7. View in: PubMed

5,6-Dihydrocyclopenta[c][1,2]-dithiole-3(4H)-thione is a promising cancer chemopreventive agent in the urinary bladder. Chem Biol Interact. 2009 Jun 15; 180(1):119-26. View in: PubMed

Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer. Int J Cancer. 2009 Jun 15; 124(12):2893-8. View in: PubMed

Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis. Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1899-903. View in: PubMed

Epithelioid sarcoma of the vulva in a 17-year-old pregnant woman. Appl Immunohistochem Mol Morphol. 2009 May; 17(3):270-3. View in: PubMed

Gynecological malignancies in Maroua, Cameroon. Int J Gynaecol Obstet. 2009 Feb; 104(2):148-9. View in: PubMed

The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: a case report. Gynecol Oncol. 2008 Dec; 111(3):527-9. View in: PubMed

Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: mystery resolved? Int J Gynecol Pathol. Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: mystery resolved? Int J Gynecol Pathol. 2008 Oct; 27(4):539-46. View in: PubMed

The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus. Histopathology. 2008 Oct; 53(4):490-5. View in: PubMed

Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas. Eur J Cancer. 2008 Oct; 44(15):2097-100. View in: PubMed

No association of NAD(P)H quinone oxidoreductase 1 expression with p53 expression or tumour outcome in patients with superficial and minimally invasive urothelial bladder cancers. BJU Int. 2008 Aug 05; 102(5):639. View in: PubMed

Intraobserver and interobserver variability in distinguishing between endocervical and endometrial adenocarcinoma on problematic cases of cervical curettings. Int J Gynecol Pathol. 2008 Jul; 27(3):431-6. View in: PubMed

The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon. Int J Gynecol Cancer. 2008 Jul-Aug; 18(4):761-5. View in: PubMed

Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma. Am J Clin Pathol. 2008 Jun; 129(6):918-23. View in: PubMed

Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer. Clin Cancer Res. 2008 Jun 01; 14(11):3283-90. View in: PubMed

Array-based comparative genomic hybridization (aCGH) analysis is a useful tool for distinguishing primary pulmonary from metastatic neuroendocrine carcinoma to the lung. Appl Immunohistochem Mol Morphol. 2008 May; 16(3):291-5. View in: PubMed

Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2008 Mar; 17(3):571-7. View in: PubMed

Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res. 2008 Mar 01; 68(5):1593-600. View in: PubMed

Primary squamous cell carcinoma of the endometrium: a case report. Eur J Gynaecol Oncol. 2008; 29(5):527-30. View in: PubMed

Desmoplastic small round cell tumor (DSRCT) with ovarian involvement in 2 young women. Appl Immunohistochem Mol Morphol. 2008 Jan; 16(1):94-9. View in: PubMed

Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis. BJU Int. 2007 Nov; 100(5):1182-7. View in: PubMed

Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. Clin Cancer Res. 2007 Oct 01; 13(19):5889-96. View in: PubMed

Challenges in array comparative genomic hybridization for the analysis of cancer samples. Genet Med. 2007 Sep; 9(9):585-95. View in: PubMed

Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer. Obstet Gynecol. 2007 Aug; 110(2 Pt 2):543-5. View in: PubMed

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer. Proc Natl Acad Sci U S A. 2007 Jul 31; 104(31):12837-42. View in: PubMed

Synovial sarcoma of the larynx in a 79-year-old woman, confirmed by karyotyping and fluorescence in situ hybridization analysis. Ann Diagn Pathol. 2007 Jun; 11(3):223-7. View in: PubMed

Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease. Leukemia. 2007 Jun; 21(6):1324-7. View in: PubMed

Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. J Clin Pathol. 2007 Jun; 60(6):694-700. View in: PubMed

Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis. J Clin Pathol. 2007 Jun; 60(6):709-14. View in: PubMed

Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary. Int J Gynecol Pathol. 2007 Apr; 26(2):154-9. View in: PubMed

Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique. Histopathology. 2007 Mar; 50(4):472-83. View in: PubMed

Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy. J Clin Pathol. 2007 Feb; 60(2):185-9. View in: PubMed

Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood. 2007 Jan 01; 109(1):331-8. View in: PubMed

Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors. Int J Gynecol Pathol. 2007 Jan; 26(1):10-5. View in: PubMed

Induction of GST and NQO1 in cultured bladder cells and in the urinary bladders of rats by an extract of broccoli (Brassica oleracea italica) sprouts. J Agric Food Chem. 2006 Dec 13; 54(25):9370-6. View in: PubMed

Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies. Histopathology. 2006 Dec; 49(6):569-75. View in: PubMed

Ewing sarcoma/primitive neuroectodermal tumor of the kidney: a case report. Diagnosed by immunohistochemistry and molecular analysis. Ann Diagn Pathol. 2006 Dec; 10(6):363-6. View in: PubMed

OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer. Int J Oncol. 2006 Oct; 29(4):903-10. View in: PubMed

The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol. 2006 Oct; 80(4):697-704. View in: PubMed

The recurrence of cervical intraepithelial neoplasia in HIV-positive women: a review of the literature. Int J STD AIDS. 2006 Aug; 17(8):507-11. View in: PubMed

Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up. Eur J Surg Oncol. 2006 May; 32(4):439-44. View in: PubMed

Ovarian primary primitive neurectodermal tumor coexisting with endometrioid adenocarcinoma: a case report. Int J Gynecol Pathol. 2006 Apr; 25(2):151-4. View in: PubMed

Genetic alterations in urothelial bladder carcinoma: an updated review. Cancer. 2006 Mar 15; 106(6):1205-16. View in: PubMed

Potential predictive patterns of minimal residual disease detected by immunohistochemistry on bone marrow biopsy specimens during a long-term follow-up in patients treated with cladribine for hairy cell leukemia. Arch Pathol Lab Med. 2006 Mar; 130(3):374-7. View in: PubMed

FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer. Eur J Surg Oncol. 2006 Mar; 32(2):231-7. View in: PubMed

Mucoepidermoid carcinoma of Stensen's duct: a case report and review of the literature. Head Neck. 2005 Sep; 27(9):829-33. View in: PubMed

14-3-3 proteins--an update. Cell Res. 2005 Apr; 15(4):228-36. View in: PubMed

MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood. 2005 Apr 01; 105(7):2891-9. View in: PubMed

Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. Mod Pathol. 2005 Mar; 18(3):340-8. View in: PubMed

Immunohistochemical expression of 14-3-3 sigma protein in human urological and gynecological tumors using a multi-tumor microarray analysis. Pathol Int. 2005 Feb; 55(2):77-82. View in: PubMed

EB-D fibronectin expression in squamous cell carcinoma of the head and neck. Oral Oncol. 2005 Jan; 41(1):82-8. View in: PubMed

Human achaete-scute homologue (hASH1) mRNA level as a diagnostic marker to distinguish esthesioneuroblastoma from poorly differentiated tumors arising in the sinonasal tract. Am J Clin Pathol. 2004 Jul; 122(1):100-5. View in: PubMed

Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Cancer. 2004 Jun 01; 100(11):2367-75. View in: PubMed

Pre-eclampsia and peripartum cardiomyopathy in molar pregnancy: clinical implication for maternally imprinted genes. Ultrasound Obstet Gynecol. 2004 Apr; 23(4):398-401. View in: PubMed

Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck. Br J Cancer. 2004 Jan 26; 90(2):471-5. View in: PubMed

Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression. Cancer. 2003 Oct 15; 98(8):1649-57. View in: PubMed

Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol. 2003 Oct; 27(10):1302-12. View in: PubMed

High efficacy of photodynamic therapy on rat endometrium after systemic administration of benzoporphyrin derivative monoacid ring A. Hum Reprod. 2003 Aug; 18(8):1707-11. View in: PubMed

Value of immunohistochemistry in staging T1 urothelial bladder carcinoma. Eur Urol. 2002 Nov; 42(5):459-63. View in: PubMed

Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma. Hum Pathol. 2002 Nov; 33(11):1136-40. View in: PubMed

Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study. Int J Gynecol Pathol. 2002 Oct; 21(4):401-6. View in: PubMed

Pathologic quiz case. Uterine polypoid mass in a postmenopausal patient following tamoxifen treatment for breast cancer. Arch Pathol Lab Med. 2002 Sep; 126(9):1125-6. View in: PubMed

Detecting bacteria in platelet concentrates by use of reagent strips. Transfusion. 2002 Aug; 42(8):1027-31. View in: PubMed

Myelodysplastic syndrome: review of the cytogenetic and molecular data. Crit Rev Oncol Hematol. 2001 Dec; 40(3):229-38. View in: PubMed

Glassy cell carcinoma of the endometrium: a case report and review of the literature. Arch Pathol Lab Med. 2001 Jun; 125(6):816-9. View in: PubMed

Testicular atrophy in 80 HIV-positive patients: a multivariate statistical analysis. Int J STD AIDS. 2001 Apr; 12(4):221-4. View in: PubMed

Cytochemical staining and flow cytometry methods applied to the diagnosis of acute leukemia in the pediatric population: an assessment of relative usefulness. J Pediatr Hematol Oncol. 2001 Feb; 23(2):89-92. View in: PubMed

Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol. 2000 Nov; 114(5):754-9. View in: PubMed

A spectrum of histopathologic findings in autoimmune liver disease. Am J Clin Pathol. 2000 Nov; 114(5):705-11. View in: PubMed

Natural killer-cell lymphoma involving the gynecologic tract. Arch Pathol Lab Med. 2000 Oct; 124(10):1510-3. View in: PubMed

Inherited giant platelet disorders. Classification and literature review. Am J Clin Pathol. 2000 Feb; 113(2):176-90. View in: PubMed

Powered bySC CTSI